SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy
about
SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
SGLT2 inhibitor dapagliflozin ...... inuric nondiabetic nephropathy
@en
SGLT2 inhibitor dapagliflozin ...... inuric nondiabetic nephropathy
@nl
type
label
SGLT2 inhibitor dapagliflozin ...... inuric nondiabetic nephropathy
@en
SGLT2 inhibitor dapagliflozin ...... inuric nondiabetic nephropathy
@nl
prefLabel
SGLT2 inhibitor dapagliflozin ...... inuric nondiabetic nephropathy
@en
SGLT2 inhibitor dapagliflozin ...... inuric nondiabetic nephropathy
@nl
P2093
P2860
P1433
P1476
SGLT2 inhibitor dapagliflozin ...... inuric nondiabetic nephropathy
@en
P2093
Carlamaria Zoja
Cristina Zanchi
Daniela Corna
Domenico Cerullo
Marina Morigi
Monica Locatelli
Paola Cassis
Sebastian Villa
Simona Buelli
P2860
P356
10.1172/JCI.INSIGHT.98720
P407
P577
2018-08-09T00:00:00Z